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ABSTRACT 25 
Diphtheria is a debilitating disease caused by toxigenic Corynebacterium diphtheriae 26 
strains and has been effectively controlled by the toxoid vaccine, yet several recent outbreaks 27 
have been reported across the globe. Moreover, non-toxigenic C. diphtheriae strains are 28 
emerging as a major global health concern by causing severe pharyngitis and tonsillitis, 29 
endocarditis, septic arthritis and osteomyelitis. Molecular epidemiological investigations 30 
suggest the existence of outbreak-associated clones with multiple genotypes circulating around 31 
the world. Evolution and pathogenesis appears to be driven by recombination as major 32 
virulence factors, including the tox gene and pilus gene clusters, are found within genomic 33 
islands that appear to be mobile between strains. The number of pilus gene clusters and 34 
variation introduced by gain or loss of gene function correlate with the variable adhesive and 35 
invasive properties of C. diphtheriae strains. Genomic variation does not support the separation 36 
of C. diphtheriae strains into biovars which correlates well with findings of studies based on 37 
multilocus sequence typing. Genomic analyses of a relatively small number of strains also 38 
revealed a recombination driven diversification of strains within a sequence type and indicate 39 
a wider diversity among C. diphtheriae strains than previously appreciated. This suggests that 40 
there is a need for increased effort from the scientific community to study C. diphtheriae to 41 
help understand the genomic diversity and pathogenicity within the population of this 42 
important human pathogen. 43 
 44 
1. Introduction 45 
Toxigenic Corynebacterium diphtheriae are responsible for diphtheria in humans, a 46 
toxin-mediated disease of the upper respiratory tract which is generally characterized by the 47 
presence of an inflammatory pseudomembrane on the tonsils, oropharynx and pharynx causing 48 
sore throat, high temperature and potentially death (Hadfield et al., 2000). The toxin is encoded 49 
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by the tox gene within the lysogenised β-corynephage (Sangal and Hoskisson, 2014a) and can 50 
be effectively controlled by the diphtheria toxoid vaccine (Baxter, 2007). The cases of 51 
diphtheria were significantly reduced following the global immunization initiative (Galazka, 52 
2000). Yet in the 1990s, the Newly Independent States (largely Former Soviet Union) observed 53 
the largest outbreaks of Diphtheria since the introduction of mass vaccination (Vitek & 54 
Wharton, 1998). In addition, there is still considerable morbidity and mortality around the 55 
world caused by this organism (www.WHO.int) and we need to remain vigilant. 56 
Non-toxigenic C. diphtheriae strains (those that lack the tox gene) are now emerging as 57 
the cause of significant disease, especially invasive infections such as endocarditis, septic 58 
arthritis and osteomyelitis (Barakett et al., 1993; Belko et al., 2000; Edwards et al., 2011; 59 
Farfour et al., 2012; Patey et al., 1997; Poilane et al., 1995; Romney et al., 2006; Tiley et al., 60 
1993). There is also the potential for C. diphtheriae to cause skin infections which result in 61 
cutaneous diphtheria across the globe in patients with varying vaccination status and travel 62 
histories (Gordon et al., 2011; Romney et al., 2006; Huhulescu et al., 2014; Cassir et al., 2015; 63 
Nelson et al., 2016). These infections are often associated with travel to C. diphtheriae 64 
prevalent endemic areas (FitzGerald et al., 2015; Lindhusen-Lindhe et al., 2012; May et al., 65 
2014). More recently, non-toxigenic tox gene-bearing strains (NTTB) have also been reported 66 
from Europe (Zakikhany et al., 2014). These NTTB strains possess the tox gene, however 67 
mutation (a nucleotide deletion or disruption by an insertion sequence) in the A-subunit of the 68 
gene prevents expression (Zakikhany et al., 2014). These strains pose a potential threat to 69 
public through genetic reversion resulting in toxin production. Moreover, carriage of non-70 
toxigenic strains in healthy individuals, as part of the normal upper respiratory tract flora is 71 
poorly understood, but has the potential to act as a reservoir of bacteria that can undergo phage-72 
conversion and dissemination. 73 
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C. diphtheriae strains have historically been subdivided into the four biovars - gravis, 74 
intermedius, mitis and belfanti (Funke et al., 1997; Goodfellow et al., 2012). However, this 75 
biochemical differentiation appears to be dependent on technical capabilities of the laboratory 76 
and is unsupported by genomic analysis (Sangal et al., 2014a). This view is also supported by 77 
the quality assurance (Elek) tests for diphtheria diagnostics by the European diphtheria 78 
surveillance network (EDSN) where several participating laboratories could not correctly 79 
identify these biovars, particularly biovars intermedius and belfanti (Both et al., 2014; Neal 80 
and Efstratiou, 2009). 81 
Related pathogenic corynebacteria including Corynebacterium ulcerans and 82 
Corynebacterium pseudotuberculosis generally cause zoonotic infection in humans (Peel et al., 83 
1997; Taylor et al., 2010; Wagner et al., 2011; Sangal et al., 2014b) whereas C. diphtheriae 84 
appears to be largely human specific. Recent reports highlight potential host jump of C. 85 
diphtheriae to and from domesticated and wild animals (Sing et al., 2015; Zakikhany et al., 86 
2014). This is particularly important as the tox gene carrying β-corynephage is able to 87 
lysogenize all three species – C. diphtheriae, C. ulcerans and C. pseudotuberculosis and the 88 
promiscuous nature of the corynephage may result in human outbreaks of diphtheria and 89 
diphtheria-like diseases caused by non-C. diphtheriae strains.  90 
Here we aim to provide an overview of global epidemiology and evolutionary dynamics 91 
of C. diphtheriae in the light of recent work in the field, with particular emphasis on the impact 92 
of whole genome sequencing in understanding the evolution and pathogenicity of different C. 93 
diphtheriae strains. 94 
 95 
2. C. diphtheriae is genetically diverse 96 
Despite an estimated 86% global coverage of the vaccine, 7,321 cases of diphtheria 97 
were reported in 2014, mainly from the developing countries (www.WHO.int). A diphtheria 98 
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epidemic in the former Soviet Union in the 1990s resulted in >157,000 cases claiming ~5000 99 
lives (Dittmann et al., 2000). Yet, this pathogen is not under control, and the have been multiple 100 
outbreaks in different countries since 2000 including Colombia (Landazabal et al., 2001), India 101 
(Parande et al., 2014; Saikia et al., 2010), Norway (Rasmussen et al., 2011), Nigeria (Besa et 102 
al., 2014), Thailand (Wanlapakorn et al., 2014), and more recently in Brazil (Santos et al., 103 
2015), Laos (Nanthavong et al., 2015) and Indonesia (Hughes et al., 2015). 104 
The molecular epidemiology and diversity of C. diphtheriae has been investigated using 105 
a number of genotyping approaches including ribotyping, amplified fragment length 106 
polymorphism (AFLP), pulse-field gel electrophoresis (PFGE), random amplified polymorphic 107 
DNA (RAPD), clustered regularly interspaced short palindromic repeat (CRISPR) based 108 
spoligotyping and multilocus sequence typing (MLST) (Bolt et al., 2010; Damian et al., 2002; 109 
De Zoysa et al., 2008; Grimont et al., 2004; Kolodkina et al., 2006; Mokrousov et al., 2007; 110 
Mokrousov et al., 2005; Mokrousov et al., 2009; Titov et al., 2003). Most of the typing 111 
approaches exhibited some degree of correspondence (Damian et al., 2002; De Zoysa et al., 112 
2008; Kolodkina et al., 2006; Titov et al., 2003). Ribotyping was found to be more 113 
discriminatory than PFGE and AFLP (De Zoysa et al., 2008) and was the gold standard for 114 
genotyping C. diphtheriae prior to the introduction of a robust MLST approach (Bolt et al., 115 
2010; Grimont et al., 2004). The main Ribotyping scheme adhered to is that of Grimont et al., 116 
(2004) with each ribotype being allocated a geographical name based on the location of 117 
isolation; however, some previous studies followed an arbitrary nomenclature to represent 118 
different ribotypes. Ribotyping identified 34 ribotypes among 167 C. diphtheriae strains from 119 
Romania, the Russian Federation and the Republic of Moldova (Damian et al., 2002). The 120 
strains belonging to two ribotypes, C1 and C5 were predominant in Russia and Moldova 121 
whereas ribotypes C3 and C7 were isolated more frequently in Romania (Damian et al., 2002). 122 
The majority of C. diphtheriae strains were found to belong to ribotypes D1 and D4 in Belarus 123 
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(Titov et al., 2003). Remarkably, the distribution of ribotypes was found to alter between 1996 124 
and 2005 (Kolodkina et al., 2006). Interestingly, this may be the result of increased vaccination 125 
in these areas following the outbreaks, perhaps indicating some level of vaccine-driven 126 
population selection in C. diphtheriae. Overall, all these studies identified prevalent clones 127 
associated with different outbreaks, but also found that multiple genotypes were circulating 128 
within different continents, suggesting great diversity of C. diphtheriae strains within the 129 
human population (Damian et al., 2002; De Zoysa et al., 2008; Kolodkina et al., 2006; von 130 
Hunolstein et al., 2003). 131 
CRISPR based spoligotyping offered additional resolution within these ribotypes and 132 
was successfully used to characterize outbreak-associated strains from countries of former 133 
Soviet Union (Mokrousov, 2013; Mokrousov et al., 2005; Mokrousov et al., 2009). The 134 
epidemic strains from Russia that belonged to two ribotypes (Sankt-Peterburg and Rossija) 135 
were subdivided into 45 spoligotypes (Mokrousov, 2013; Mokrousov et al., 2007; Mokrousov 136 
et al., 2005). Due to the higher diversity within ribotype Sankt-Peterburg, it was proposed to 137 
have evolved prior to the emergence ribotype Rossija, indicating that new strains are emerging 138 
regularly within this species (Mokrousov, 2013). 139 
While most genotypic approaches are focused on outbreak characterization and high 140 
resolution strain discrimination, MLST is more appropriate to investigate long-term 141 
evolutionary dynamics and has been applied to a number of microorganisms prior to the 142 
emergence of cost effective genome sequencing (Maiden, 2006). A robust MLST scheme was 143 
developed for C. diphtheriae in 2010 and sequence types (STs) were shown to be consistent 144 
with the previously determined C. diphtheriae ribotypes and offered higher resolution in most 145 
cases (Bolt et al., 2010). One important feature of the MLST studies was that they revealed a 146 
lack of correlation between the STs and the widely used biovar system and also showed no 147 
correlation with the severity of the disease caused by different strains (Bolt et al., 2010; Farfour 148 
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et al., 2012). While some eBURST groups, the so called clonal complexes, were found to be 149 
associated with certain countries, others were reported from multiple continents, indicating 150 
wide dissemination of strains (Bolt et al., 2010). MLST diversity has grown since 2010 and the 151 
data for 384 reference STs is available from the MLST website 152 
(http://pubmlst.org/cdiphtheriae/; accessed in November 2015). A total of 115 of these STs 153 
formed 11 major eBURST groups where the predicted founder had three or more single locus 154 
variants (Fig. 1). However, some of these data belong to C. ulcerans strains and may also 155 
contain some erroneous submissions to the database by the public. 156 
 More recently, whole genome sequences of 20 C. diphtheriae strains have been analysed 157 
(Cerdeno-Tarraga et al., 2003; Sangal et al., 2015; Sangal et al., 2014; Sangal et al., 2012a, b; 158 
Trost et al., 2012), revealing the genetic diversity amongst and within the major STs. 159 
Approximately 60% of the genome appears to be functionally conserved within C. diphtheriae 160 
strains with 1,625 genes belonging to the core genome (Sangal et al., 2015). However, enough 161 
diversity has accumulated within the core genes to allow discrimination of most C. diphtheriae 162 
strains from each other. Strains within STs appear to show close relationships indicating the 163 
robust nature of the MLST approach (Fig. 2; Bolt et al., 2010; Sangal et al., 2015). Similar 164 
groupings were also obtained from the genome-wide single nucleotide polymorphism analysis 165 
(SNPs; Sangal et al., 2014). The accessory genome varied greatly among C. diphtheriae strains 166 
(Sangal et al., 2015) even when a relatively small number of genomes was considered (14 167 
known STs; Fig. 1). This indicates that most of the C. diphtheriae diversity remains to be 168 
discovered and will be crucial in our understanding of the molecular epidemiology, global 169 
transmission and carriage of this pathogen. 170 
 171 
3. Evolutionary dynamics 172 
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Despite the global emergence of non-toxigenic strains and multiple recent outbreaks 173 
caused by C. diphtheriae, little is known about the evolutionary dynamics of this pathogen and 174 
most of the current understanding comes from the genomic analyses. MLST analyses indicated 175 
that there is significant recombination within C. diphtheriae populations (Bolt et al., 2010). 176 
Recombination plays an important role in bacterial evolution and is often linked to the 177 
increased virulence in some strains (Joseph et al., 2011; Suarez et al., 2004; Wirth et al., 2006). 178 
Indeed, the primary niche of C. diphtheriae in humans is the upper respiratory tract which is a 179 
hot-bed of horizontal gene transfer between bacterial strains (Marks et al., 2012). 180 
A total of 57 genomic islands have been reported in C. diphtheriae and the distribution 181 
was found to vary significantly between strains (Trost et al., 2012). The genomic islands can 182 
be horizontally acquired from other bacteria, suggesting that recombination is shaping the 183 
current genetic diversity in C. diphtheriae. Some of the genomic islands carried phage 184 
associated genes while others harboured the genes that encode proteins for different cellular 185 
activities including siderophore biosynthesis and transport, degradation of polysaccharides and 186 
hydrocarbon derivatives such as 3-hydroxyphenylpropionic acid, antibiotic and heavy metal 187 
resistance (Trost et al., 2012). The major virulence factor of C. diphtheriae, the tox gene, is 188 
carried on a bacteriophage that can also move between strains, resulting in phage conversion 189 
(Barksdale and Pappenheimer, 1954; Freeman, 1951; Sangal and Hoskisson, 2014). Genomic 190 
islands carrying different spa operons introduced the variation in the ability of C. diphtheriae 191 
strains to form pili and interact with the host. These spa operons harbour genes encoding 192 
subunits of different types of pili and the gain or loss of the function of these genes correlate 193 
to the number and expression of pili on the cell surface (Ott et al., 2010; Chang et al., 2011; 194 
Trost et al., 2012).  195 
Approximately one-third of the C. diphtheriae genome encodes accessory genes that 196 
vary widely between strains (Sangal et al., 2015). The strains within individual STs differed 197 
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from each other by the presence or absence of up to 290 genes, many of which are present on 198 
the genomic islands (Sangal et al., 2015). These observations indicate likely differences in 199 
recombination frequencies between C. diphtheriae strains. The frequencies of recombination 200 
may vary widely between different strains within a species (Sangal et al., 2010), and may reflect 201 
the difference in strain propensities for acquiring foreign DNA, which may result in variation 202 
in pathogenicity of strains. Restriction-modification systems, bacteriophage defence systems 203 
and CRISPR-Cas systems are major barriers to recombination that have been reported in the 204 
genomes of C. diphtheriae strains (Hoskisson & Smith, 2007; Sangal et al., 2013). 205 
Genomic analyses of C. diphtheriae strains revealed the presence of two types of 206 
CRISPR-Cas systems in three different configurations (Sangal et al., 2013). These systems are 207 
comprised of CRISPR-associated proteins (Cas proteins encoded by cas genes) and CRISPR 208 
arrays of short spacer sequences acquired from invading bacteriophages or plasmids that are 209 
separated by repeat sequences. These arrays are transcribed into crRNA that recognizes the 210 
invasion by the same nucleic acids and activate their cleavage by Cas ribonucleoprotein 211 
complex (Marraffini, 2015). The acquisition of each spacer sequence represents a unique 212 
evolutionary event, an encounter of the bacterial cell with the bacteriophage or plasmid that 213 
may be unique to particular environment. 214 
The majority of C. diphtheriae strains carried a type II-C CRISPR-Cas system, however 215 
this was replaced by a type I-E-a in some strains or vice versa (Sangal et al., 2013). A few 216 
strains with a type II-C system possessed an additional CRISPR-Cas system, type I-E-b, at a 217 
different location in the genome. The variation in the G+C content and the phylogenetic 218 
analyses of cas1 gene, along with the direct repeat sequences in the CRISPR arrays suggest 219 
three independent horizontal acquisitions of these CRISPR-Cas systems by C. diphtheriae. 220 
Most of the spacer sequences are unique to CRISPR arrays in different strains, suggesting that 221 
these strains evolved in different environments and encountered a range of different 222 
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bacteriophages or plasmids (Sangal et al., 2013). Some strains were found to share spacer 223 
sequences at the distal end of the array, which may represent common strain ancestry or 224 
abundance of a particular foreign DNA type (bacteriophages/plasmids). The type of CRISPR-225 
Cas systems and most of the spacer sequences in the arrays were shared between individuals 226 
of the same ST, which is consistent with their evolution from a recent common ancestor. These 227 
results also support CRISPR loci as useful molecular markers for strain identification and 228 
epidemiological studies (Mokrousov, 2013; Mokrousov et al., 2007). 229 
Overall, the genomic and spacer diversities found in C. diphtheriae strains indicate 230 
unique evolutionary trajectories for different C. diphtheriae strains after they separated from 231 
their last common ancestor. However, no clear geographic or temporal association of C. 232 
diphtheriae strains has been reported. Interestingly, this may simply reflect a sampling bias, as 233 
available genomes reflect <10% of the current C. diphtheriae diversity observed from MLST 234 
analysis (Fig. 1). These data highlight the need to expand the genome sequencing effort for this 235 
species to fully understand the evolutionary dynamics of this pathogen. 236 
 237 
4. Genetic basis of biochemical differentiation 238 
The biochemical differentiation of C. diphtheriae strains into biovars is complex and 239 
unreliable, however for historical reasons it is still routinely followed by reference labortories 240 
(Both et al., 2014; Neal and Efstratiou, 2009; Sangal et al., 2014). The key characteristics 241 
include lipophilism of biovar intermedius strains - the need lipids for optimal growth and the 242 
formation of small gray or translucent colonies on agar plates (Funke et al., 1997). The strains 243 
of other biovars generally form large white or opaque colonies. The strains of biovar belfanti 244 
can not reduce nitrate and only biovar gravis strains seem to definitely utilize glycogen and 245 
starch as carbon sources (Efstratiou et al., 2000; Efstratiou and George, 1999; Goodfellow et 246 
al., 2012). 247 
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Comparative genomic analyses identified that four genes involved in carbohydrate 248 
metabolism are absent or are pseudogenes in the intermedius strain (Sangal et al., 2014), 249 
potentially suggesting that this biovar may have compromised abilities to effectively use 250 
carbohydrates as the energy source and require alternate carbon source such as lipids, for 251 
optimal growth in the host. We have previously highlighted an insertion at the 3’ end of narJ 252 
gene in the only sequenced belfanti genome, that results in an extended coding sequence in 253 
comparison to its homolog DIP0498 in NCTC 13129 (Sangal et al., 2014). However, the 254 
annotation of strain NCTC 13129 has recently been revised (GenBank accession number: 255 
NC_002935.2; new locus tag for DIP0498: DIP_RS13825) and the protein sequence of narJ is 256 
of the same length as observed in belfanti. Therefore, genetic basis of the belfanti strains not 257 
being able to reduce nitrate remains unclear. The phylogenomic analyses of core genome, 258 
accessory genome and genome-wide SNPs revealed an absence of a biovar specific grouping. 259 
Therefore, the biochemical seperation of C. diphtheriae into the traditional biovars is not 260 
supported by genomic diversityand is unsuitable for modern epidemiological studies (Sangal 261 
et al., 2015; Sangal et al., 2014; Trost et al., 2012). Genome sequencing results are consistent 262 
with the MLST phylogeny where the major C. diphtheriae lineage included strains from all 263 
four biovars (Bolt et al., 2010). However, a smaller second befanti-specific lineage can be 264 
observed from the MLST analyses which is not detected in the genomic study, potentially 265 
because the genome sequence of only one strain for each of the biovars belfanti and intermedius 266 
is available that highlights a clear need for more strains of these biovars to be sequenced. 267 
 268 
5. Variation in pathogenicity and invasive strains  269 
C. diphtheriae is considered a paradigm of mucosal pathogenicity, with much of the 270 
research focused on toxin production and pseudomembrane formation, almost to the neglect of 271 
studying other virulence mechanisms, such that the discovery of invasive strains of C. 272 
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diphtheriae was a surprise to researchers. The tox gene, encoding the diphtheria toxin, is 273 
harboured on the genome of the β-corynephage, which integrates into C. diphtheriae genome 274 
between duplicated arginine tRNA genes (Sangal and Hoskisson, 2014; Trost et al., 2012). 275 
Only one prophage is present in most toxigenic strains, with the exception of strain PW8 where 276 
two copies of corynephage ωtox+ is found (Sangal and Hoskisson, 2014; Trost et al., 2012). 277 
While the nucleotide sequence of different corynephages show high levels of diversity, the 278 
sequence of the tox gene is highly conserved and also reflects the efficacy of the toxoid vaccine. 279 
The transcription of tox gene is controlled by the DtxR regulon, which is a key determinant for 280 
iron homeostasis (De Zoysa et al., 2005; Fourel et al., 1989). Iron is involved in a number of 281 
cellular activities and the induction of toxin in low iron availability might help pathogens to 282 
compete with the host for iron (Ganz and Nemeth, 2015; Trost et al., 2012) or liberate iron 283 
through killing of host cells. The gene composition of DtxR regulons in different C. diphtheriae 284 
strains may vary due to gain or loss of the genes that may affect the iron supply to the bacterial 285 
cell and hence, the expression of the tox gene (Litwin and Calderwood, 1993; Trost et al., 286 
2012). 287 
Non-toxigenic C. diphtheriae strains by definition do not contain the tox carrying β-288 
corynephage, but do vary in their abilities to adhere to host cells, intracellular viability and 289 
their ability to stimulate cytokine production by the host immune system which may influence 290 
the severity of the disease due to infection (Bertuccini et al., 2004; Hirata et al., 2002; Peixoto 291 
et al., 2014; Puliti et al., 2006). These strains differ from each other in the presence and 292 
organisation of different pilus gene clusters, spaA, spaD and spaH (Sangal et al., 2015; Trost 293 
et al., 2012). Two pilus gene clusters, spaD and spaH, were present in four C. diphtheriae 294 
strains that exhibited different adhesive and invasive properties. Interestingly, the spaA operon 295 
was only present in the two strains with higher adhesion to pharyngeal D562 cell lines (Ott et 296 
al., 2010; Sangal et al., 2015). SpaA pili have been shown to interact with the pharyngeal 297 
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epithelial cells and SpaD and SpaH with the laryngeal and lung epithelial cell types (Mandlik 298 
et al., 2007; Reardon-Robinson and Ton-That, 2014) suggesting niche specialised roles for 299 
specific pilus types. However, some genes were found to be pseudogenes in these clusters 300 
(Sangal et al., 2015), for example, srtB gene that encodes sortase for incorporation of SpaE 301 
into the SpaD subunit of SpaD-type pili, spaG encoding a subunit of SpaH-type pili and spaB 302 
encoding pilus base subunit of SpaA-type pili were pseudogenes in strains ISS 4060, ISS 3319 303 
and ISS 4746, respectively (Reardon-Robinson and Ton-That, 2014; Sangal et al., 2015). In 304 
addition, a gene spaF that encodes surface anchored fimbrial subunit of spaD-type pili was 305 
pseudogenitised both in ISS 4746 and ISS 4749. Strain ISS 4749 with two intact gene clusters 306 
(SpaA and SpaH) exhibited highest number of pili at the cell surface and highest adhesion to 307 
the cell lines when compared to ISS 3319 (SpaD gene cluster) and ISS 4746 (SpaH gene 308 
cluster) with only one intact gene cluster (Bertuccini et al., 2004; Ott et al., 2010; Sangal et al., 309 
2015). Although SpaH gene cluster appears to be fully functional in ISS 4060 strain, no surface 310 
pili were observed, suggesting there may be variation in the levels of gene expression. 311 
However, adhesive properties of this strain were comparable to ISS 3319 (Bertuccini et al., 312 
2004; Ott et al., 2010; Sangal et al., 2015). Therefore, the macromolecular surface structure 313 
and cell adhesion properties generally correlate to the presence of pilus gene clusters in C. 314 
diphtheriae and expression of these genes may be subject to unknown gene regulation 315 
mechanisms. 316 
ISS 4746 and ISS 4749 were also shown to induce higher cytokine (IL-1 and IL-6) 317 
production and caused higher incidences and severity of arthritis in mice in comparison to ISS 318 
3319 (Puliti et al., 2006). In addition to the membrane associated proteins, comparative 319 
genomic analyses revealed a variation in predicted secreted proteins including lipoproteins and 320 
non-classical secreted proteins among these strains, which may be associated with the variation 321 
in the degree of pathogenesis (Sangal et al., 2015). Most of these proteins are hypothetical and 322 
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a molecular characterization of these proteins might further improve understanding of the 323 
mechanisms of adhesion, invasion and immune induction in C. diphtheriae. 324 
 325 
6. Conclusions 326 
C. diphtheriae is still a major human pathogen, with multiple contemporary outbreaks 327 
around the world. Moreover, non-toxigenic strains are beginning to cause significant invasive 328 
disease in patients. Genomic analyses not only identified potential genes involved in adhesive, 329 
invasive and virulence characteristics of C. diphtheriae strains but also highlighted the impact 330 
of horizontal gene transfer in acquisition of these genes. These analyses also raise concerns 331 
about the use of biochemical separation of C. diphtheriae strains into biovars in clinics as a 332 
biovar encompasses genetically distinct strains. The evolutionary dynamics and the global 333 
diversity in C. diphtheriae are poorly characterized, clearly emphasizing the need of a 334 
community-based genome sequencing program that will improve the understanding of global 335 
transmission and local adaptation and will facilitate the development of effective surveillance 336 
policies and preventive strategies, amid multiple ongoing outbreaks. It will also inform on 337 
future vaccine development, perhaps to augment existing toxoid-based vaccines with universal 338 
surface proteins from C. diphtheriae which may be more effective in reducing carriage and the 339 
invasive diseases caused by non-toxigenic strains. 340 
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Figure Legends 597 
Fig. 1. An eBURST diagram from the MLST profiles of reference STs from the MLST website 598 
(http://pubmlst.org/cdiphtheriae/). The predicted founder STs are shown in blue and co-founder 599 
STs are shown in yellow. Single locus variants (SLVs) are connected to each other and major 600 
groups where predicted founder has three or more SLVs are labelled. The known STs for C. 601 
ulcerans are shown in cyan. ST with some genome sequenced strains are encircled in red. 602 
 603 
Fig. 2. A phylogenetic tree from the core genome of C. diphtheriae (adapted from Sangal et 604 
al., 2015). ST designations are mapped on the tree in parentheses, if known.  The strains biovars 605 
gravis, mitis, belfanti and intermedius are labelled in red, green, purple and blue, respectively. 606 
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